Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on April 25, 2025

Raising Orchid Kids Condemns Secretary Kennedy's Harmful Comments on Autistic Kids, Adults and Families
D.C. area coaches dedicated to supporting families of neurodivergent children speak out against RFK's inaccurate, misleading and harmful comments about autism. WASHINGTON, DC, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Raising Orchid Kids, a …

Caring Critters and The Alphabet They Share: A Book About Love, Kindness, and Empathy
TIGARD, OR, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Caring Critters and the Alphabet They Share: A Book About Love, Kindness, and Empathy Caring Critters and the Alphabet They Share by Donna L. Botteen offers young readers a joyful, values …

Evaluating Candidacy for Testosterone Therapy: Medical Indicators and Considerations
METAIRIE, LA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Testosterone therapy has become a topic of growing interest among individuals experiencing symptoms commonly associated with hormonal imbalance or age-related testosterone decline. …

Spectrum Spine is proud to introduce it's new CEO, Kelly Shelton
Spectrum Spine Inc, a medical device manufacturer introducing disruptive technology in the Orthopedic and Spinal Implant space announces new CEO, Kelly Shelton. INLET BEACH, FL, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Spectrum Spine Inc. is …

Baylink Presents New Preclinical Data At The American Association For Cancer Research (AACR) Annual Meeting
PALO ALTO, CA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Preclinical results for lead ADC candidate BLB-101 for Claudin 6/9+ tumors supports potential best-in-class profile. Data presented demonstrating Baylink’s innovative ADC linker …

GenBio Is Pleased to Share the Latest Neuroprotective Research in Alzheimer’s disease (AD)
Crossing The Blood-Brain Barrier (BBB) The Power of Purple! ALISO VIEJO, CA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Alzheimer’s disease is a progressive neurodegenerative disorder where patients suffer a gradual deterioration of memory and …

Changing Life & Destiny Conference 2025 Kicks Off in Dallas, Uniting Leaders in Functional Health and Longevity
DALLAS, TX, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- The highly anticipated Changing Life …

Mental Health Counselor Amber Windsor PhD Recently Featured on Close Up Radio
GLASSBORO, NJ, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Amber Windsor is a counselor who works with youth in crises and helps them realize what they are going through is not bad or wrong, but simply a diagnosis, and that they can still be good …

WinPure Partners with Moonsoft Oy to Deliver Powerful Data Quality Management Solutions Across the Nordics and Baltics
READING, BERKSHIRE, UNITED KINGDOM, April 25, 2025 /EINPresswire.com/ -- WinPure, a global leader in data quality software, is proud to announce a strategic partnership with Moonsoft Oy, a leading Finnish software distributor specializing in enterprise …

Biological roles for three strand DNA and RNA flipon structures
The cell's version of the multiverse! Here, the focus is on three-stranded DNA and RNA triplex structures. Their biological relevance is now coming into focus. CHARLESTOWN, MA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- A paper released on …

Loveland, CO Clinic Offers Personalized IV Therapy For Chronic and Acute conditions
Suite Health – (970-315-1891) Outpatient Infusion offers IV therapy in Loveland, CO, providing treatment for chronic and acute conditions. LOVELAND, CO, UNITED STATES, April 26, 2025 /EINPresswire.com/ -- https://www.mysuitehealth.com/ - Suite Health …

Korean Chemical Society and Enamine Partner to Advance Chemical Research
SUWON, SOUTH KOREA, April 25, 2025 /EINPresswire.com/ -- Korean Chemical Society (KCS), an academic organization that promotes research and education in the field of chemistry and the chemistry profession, and Enamine, the leading provider of chemical …

Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees
FLORHAM PARK, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that Nasdaq has notified the Company that it has not paid certain fees …

Rezolute, Inc. Announces Closing of Underwritten Offering
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare diseases, today announced the closing …

New Data at AACR Annual Meeting Highlights Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Distant Metastasis
FRIENDSWOOD, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will share new research intended to improve the care of patients with cutaneous and …

Hartcoin Launches Most Profitable AI-Powered Cloud Mining Platform of 2025 Amid Market Uncertainty
LONDON, UK , April 25, 2025 (GLOBE NEWSWIRE) -- Amid ongoing volatility in global markets and the cryptocurrency sector, Hartcoin, an AI-powered cloud mining platform, is drawing worldwide attention by providing one of the most profitable and accessible …

MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 Zug, Switzerland, April 25, 2025 – MoonLake Immunotherapeutics (Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory …

Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting
SALT LAKE CITY, April 25, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced new clinical data will be shared at the American Association for Cancer Research (AACR) …

Prelude Announces Presentations at 2025 AACR Annual Meeting
Preclinical data elucidating the mechanism of action of PRT3789, Prelude’s first-in-class, highly selective SMARCA2 degrader currently in early clinical development Highlights from Prelude’s efforts to discover and develop selective KAT6A degraders, …

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance
IRVINE, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications …